2Kremer JM, Wilting J, Janssen LH. Drug binding to human alpha-1-acid glycoprotein in health and disease[J]. Pharmacol Rev, 1988; 40:1-47
3Reidenberg MM, Erill S. Drug-protein binding[M]. New York: Praeger Publishers, 1986
4Meyer MC, Guttman DE. The binding of drugs by plasma proteins[J]. J Pharm Sci, 1968; 57: 895-918
5Oravcova J, Bohs B, Lindner W. Drug-protein binding sites.New trends in analytical and experimental methodology[ J]. J Chromatogr B Biomed Appl, 1996; 677:1 - 28
6Wright JD, Boudinot FD, Ujhelyi MR. Measurement and analysis of unbound drug concentrations [J]. Clin Pharmacokinet,1996; 30: 445- 62
7Heringa MB, Pastor D, Algra J, Vaes WH, Hermens JL. Negligible depletion solid-phase microextraction with radiolabeled analytes to study free concentrations and protein binding: an example with [3H]estradiol[J]. Anal Chem, 2002; 74: 5993-7
8Dockal M, Carter DC, Ruker F. Conformational transitions of the three recombinant domains of human serum albumin depending on pH[J]. J Biol Chem, 2000; 275:3042-50
9Dockal M, Carter DC, Ruker F. The three recombinant domains of human serum albumin. Structural characterization and ligand binding properties[J]. J Biol Chem, 1999; 274:29303- 10
10Colmenarejo G. In silico prediction of drug-binding strengths to human serum albumin [J]. Med Res Rev, 2003; 23: 275 -301
